Achieve Life Sciences shareholders reject director equity plan increase

ACHIEVE LIFE SCIENCES, INC.

All seven director nominees elected with majority 'for' votes; broker non-votes 11,422,484.
Ratification of PwC as auditor for FY2025 approved: 26,459,791 for, 53,879 against.
Amendment to 2023 Non-Employee Director Equity Incentive Plan to increase shares failed: 6,736,105 for, 7,982,633 against.
Proposal required majority of votes cast; failure may impact director compensation strategy.
Broker non-votes (11,422,484) were not counted on non-routine matters, effectively against the plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.